(Q34448373)

2 August 2017

1 reference

title

Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives (English)

1 reference

2 August 2017

0 references

Kjaer A

1

1 reference

PubMed ID

11722473

2 August 2017

Hesse B

series ordinal

2

1 reference

2 August 2017

1 November 2001

1 reference

2 August 2017

1 reference

2 August 2017

21

1 reference

2 August 2017

6

1 reference

2 August 2017

661-672

1 reference

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

2 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Tissue renin-angiotensin system in myocardial hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Baroreflex loading maneuvers do not suppress increased plasma arginine vasopressin in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Endothelium-dependent vasodilation is attenuated in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Endothelial nitric oxide pathway function in the peripheral vasculature of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Biochemical detection of left-ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Increased human brain natriuretic peptide in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Increased plasma concentrations of endothelin in congestive heart failure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Plasma norepinephrine in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Angiotensin II type 2 receptor mediates programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Plasma endothelin and pulmonary pressures in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2281.2001.00371.X

10.1046/J.1365-2281.2001.00371.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11722473